/BBAGF
BBAGF Stock - BB Biotech AG
Financial Services|Asset ManagementOTC
$54.93+435393246181233280.00%
+$54.93 (+435393246181233280.00%) • Nov 19
74
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.90
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.86
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $60.42
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for BBAGF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$54.38 – $55.48
TARGET (TP)$63.17
STOP LOSS$50.54
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.84
52W High$55.01
52W Low$33.65
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $111.63M | $-193,765,000 | $-349,501,000 | $-395,234,000 | $699.23M |
| Gross Profit | $111.63M | $-199,567,000 | $-351,227,000 | $-396,220,000 | $699.23M |
| Gross Margin | 100.0% | 103.0% | 100.5% | 100.2% | 100.0% |
| Operating Income | $84.40M | $-206,527,000 | $-38,621,000 | $-52,595,000 | $700.01M |
| Net Income | $75.90M | $-206,607,000 | $-357,812,000 | $-404,808,000 | $691.17M |
| Net Margin | 68.0% | 106.6% | 102.4% | 102.4% | 98.8% |
| EPS | $1.38 | $-3.77 | $-6.50 | $-7.31 | $12.48 |
Company Overview
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
BBAGFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-2.30
Q3 2025
EPS Surprise History
Q1 24
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Jul 25, 2025 | — | $-2.30 | — | — |
Q2 2025 | Apr 25, 2025 | — | $-5.17 | — | — |
Q1 2025 | Feb 21, 2025 | — | $1.20 | — | — |
Q4 2024 | Oct 25, 2024 | — | $-3.31 | — | — |
Q3 2024 | Jul 26, 2024 | — | $-1.79 | — | — |
Q2 2024 | Apr 26, 2024 | — | $5.21 | — | — |
Q1 2024 | Feb 16, 2024 | — | $2.33 | — | — |
Q1 2024 | Jan 19, 2024 | — | $-0.96 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.27 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-5.03 | — | — |
Q1 2023 | Feb 20, 2023 | — | $-0.69 | — | — |
Q4 2022 | Oct 21, 2022 | — | $3.89 | — | — |
Q3 2022 | Jul 22, 2022 | — | $-4.42 | — | — |
Q2 2022 | Apr 22, 2022 | — | $-5.87 | — | — |
Q1 2022 | Feb 18, 2022 | — | $-10.79 | — | — |
Q4 2021 | Oct 22, 2021 | — | $-4.04 | — | — |
Q3 2021 | Jul 23, 2021 | — | $2.51 | — | — |
Q2 2021 | Apr 23, 2021 | — | $4.24 | — | — |
Q1 2021 | Jan 22, 2021 | — | $11.87 | — | — |
Q4 2020 | Oct 23, 2020 | — | $-7.75 | — | — |
Latest News
Loading news...
Frequently Asked Questions about BBAGF
What is BBAGF's current stock price?
BB Biotech AG (BBAGF) is currently trading at $54.93 per share. The stock has moved +435393246181233280.00% today.
What is the analyst price target for BBAGF?
No analyst price targets are currently available for this stock.
What sector is BB Biotech AG in?
BB Biotech AG operates in the Financial Services sector, specifically within the Asset Management industry. The company is traded on the OTC exchange.
What is BBAGF's market cap?
BB Biotech AG has a market capitalization of $4.22 billion, making it a mid-cap company.
Does BBAGF pay dividends?
No, BB Biotech AG does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorAVGTF
AVI Global Trust plc
$3.35
Mkt Cap: $1.4B
BLGFF
Baillie Gifford US Growth Trust PLC
$3.85
Mkt Cap: $1.6B
BWMTF
BlackRock World Mining Trust plc
$7.00
Mkt Cap: $1.3B
CYLTF
The City of London Investment Trust plc
$6.79
Mkt Cap: $3.4B
EHITF
The Edinburgh Investment Trust plc
$10.88
Mkt Cap: $1.5B
HNDEF
Henderson European Trust Plc
$3.32
Mkt Cap: $1.6B
MNKIF
The Monks Investment Trust PLC
$14.73
Mkt Cap: $2.9B
TEUUF
The European Smaller Companies Trust PLC
$1.96
Mkt Cap: $0.9B
TXEMF
Templeton Emerging Markets Investment Trust plc
$2.40
Mkt Cap: $2.3B
WTNTF
Witan Investment Trust plc
$2.83
Mkt Cap: $1.8B
Explore stocks similar to BBAGF for comparison